Erratum To: Effects on Bone Metabolism Markers and Arterial Stiffness by Switching to Rivaroxaban From Warfarin in Patients With Atrial Fibrillation

Heart and Vessels - Japan
doi 10.1007/s00380-017-0966-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Patient Satisfaction After Switching From Warfarin to Apixaban in Patients With Nonvalvular Atrial Fibrillation: AGAIN Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
2020English

Hospital Length of Stay: Does Rivaroxaban Reduce Inpatient Stay Compared to Warfarin Among Patients With Non-Valvular Atrial Fibrillation?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Role Fibrosis Markers to Stratify Risk of Atrial Fibrillation in Patients With Arterial Hypertension and Ekstakardialnoy Pathology

Современные проблемы науки и образования (Modern Problems of Science and Education)
2018English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Examining Warfarin Underutilization Rates in Patients With Atrial Fibrillation: Detailed Chart Review Essential to Capture Contraindications to Warfarin Therapy

Thrombosis Journal
Hematology
2008English

Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients With Nonvalvular Atrial Fibrillation

Journal of Nihon University Medical Association
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy